Targeted Approach To OPPS Outlier Policy Advocated By MedPAC’s DeParle
This article was originally published in The Gray Sheet
Limiting OPPS "outlier" payments to specific dollar thresholds and ambulatory payment classifications (APCs) should be considered by the Centers for Medicare & Medicaid Services, according to MedPAC member Nancy-Ann DeParle, JPMorgan Partners
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.